Dr. Michael Cecchini
Claim this profileYale University
Studies Pancreatic Cancer
Studies Colorectal Cancer
8 reported clinical trials
15 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
MET positive
KRAS positive
2Colorectal Cancer
Stage IV
MET positive
Stage III
Affiliated Hospitals
Clinical Trials Michael Cecchini is currently running
Temozolomide + Tuvusertib
for Cancer
This trial tests a combination of two drugs, temozolomide and M1774, in patients with advanced cancer that has spread. Temozolomide damages cancer cell DNA, while M1774 blocks growth enzymes. The goal is to find a more effective treatment for these patients.
Recruiting1 award Phase 1 & 2
LY4066434
for Solid Tumors
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatments. The study will have 2 parts: monotherapy dose escalation and dose optimization. The study is expected to last up to approximately 5 years.
Recruiting1 award Phase 14 criteria
More about Michael Cecchini
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Michael Cecchini has experience with
- Olaparib
- Ramucirumab
- Temozolomide
- Tuvusertib
- BAY 1895344
- Irinotecan Hydrochloride
Breakdown of trials Michael Cecchini has run
Pancreatic Cancer
Colorectal Cancer
Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Cecchini specialize in?
Michael Cecchini focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are MET positive.
Is Michael Cecchini currently recruiting for clinical trials?
Yes, Michael Cecchini is currently recruiting for 5 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Michael Cecchini has studied deeply?
Yes, Michael Cecchini has studied treatments such as Olaparib, Ramucirumab, Temozolomide.
What is the best way to schedule an appointment with Michael Cecchini?
Apply for one of the trials that Michael Cecchini is conducting.
What is the office address of Michael Cecchini?
The office of Michael Cecchini is located at: Yale University, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.